(Index) Industry Reviews
Angel and Venture Alert: The Case for Investing in Orphan Drugs

Angel and Venture Alert: The Case for Investing in Orphan Drugs

No, we’re not talking about developing drugs for orphans. But for 25 million Americans, according to the NIH, an “Orphan Drug” (one that serves fewer than 200k users and includes diseases such as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, among others) can spell the difference between misery (or worse) and getting through the day. How are traditional vs. orphan drugs...

read more
Why Pay Attention to Blue Gem Coal?

Why Pay Attention to Blue Gem Coal?

Okay, I know. Most people think of “dirty” coal or the Coal Miner’s Daughter. Understandably so, if those types of coal constitute greater than 95% of all the world’s known coal reserves. Did you know that Blue Gem Coal (and some valuable minerals derived from it) is used to make clean solar panels, cell phones, and other critical technologies and commodities used around the world by consumers...

read more
The U.S. Solar market is going mainstream.

The U.S. Solar market is going mainstream.

It might be surprising to many investors to learn how large and how quickly the solar power market is growing.  In 2017, 30% of all new U.S. electric generating capacity came from solar, ranking 2nd only to natural gas.In 2010, only 4% came from solar. And what may be even more surprising is that the U.S. solar installed capacity is expected...

read more

WHITE PAPERS

VIDEOS

NEWSLETTER

INVESTMENT TERMS

In the interest of accessibility, here are some terms that any investor should be familiary with.